Several top medical device companies this week had legal issues come up. Johnson & Johnson, still upset over losing Guidant to Boston Scientific, is suing the aforementioned company for $4 billion. Meanwhile Becton Dickinson is being court ordered to notify customers about its false advertisements for its safety syringes. And as if being sued for $4 billion wasn’t enough, Boston Scientific has been ordered to pay out $26.7 million to four women in their vaginal mesh lawsuit. Sometimes being at the top isn’t all it’s cracked up to be. Johnson
Read MoreThe month of October not only brought us the beginning of the Autumn season, ghosts and ghouls, and surprisingly warm weather, but it also brought the medical device world into greater focus, what with an influx of investments from venture capitalists as well as new and on-going mergers. As far as VCs go, it looks like their pocket books continue to show significant interest in the medical device space. Cognoptix, a small medical device company specializing in an eye test for diagnosing Alzheimer’s disease, received $15M in Series D financing
Read MoreThere were a number of stories this week in the news that revolved around the treatment of peripheral artery disease. Peripheral artery disease (PAD) is when the arteries narrow and there is restricted blood flow to the limbs. Often times it is caused by the buildup of plaque in the artery walls. Medtronic and Shockwave Medical had promising studies released this week showing that their drug-coated balloons could help treat PAD while Covidien was cleared by the FDA for its directional atherectomy system. Medtronic’s device, the IN.PACT Admiral drug-coated balloon,
Read More